Exhibit 4.10
REGISTRATION RIGHTS AGREEMENT
THIS REGISTRATION RIGHTS AGREEMENT, dated as of May 10,
2001 between Sativum Investments Limited ("Purchaser") and StemCells, Inc.
(the "Company").
WHEREAS, simultaneously with the execution and delivery of
this Agreement, the parties shall enter into the Common Stock Purchase
Agreement, dated as of the date hereof, (the "Purchase Agreement") pursuant
to which the Purchaser has committed to purchase up to $30,000,000 of the
Company's Common Stock (terms not defined herein shall have the meanings
ascribed to them in the Purchase Agreement) and the Warrant; and
WHEREAS, the execution and delivery of this Agreement and
granting to the Purchaser of the registration rights set forth herein with
respect to the Shares is a component part of the transaction contemplated
under the Purchase Agreement.
NOW, THEREFORE, the parties hereto mutually agree as
follows:
Section 1. REGISTRABLE SECURITIES. As used herein the term
"Registrable Security" means all Shares that (i) have not been sold under the
Registration Statement, (ii) have not been sold under circumstances under
which all of the applicable conditions of Rule 144 (or any similar provision
then in force) under the Securities Act ("Rule 144") are met, (iii) have not
been otherwise transferred to persons who may trade such Shares without
restriction under the Securities Act, and the Company has delivered a new
certificate or other evidence of ownership for such Shares not bearing a
restrictive legend, or (iv) may not be sold without any time, volume or
manner limitations pursuant to Rule 144(k) (or any similar provision then in
effect) in the opinion of counsel to the Company under the Securities Act. In
the event of any merger, reorganization, consolidation, recapitalization or
other change in corporate structure affecting the Common Stock, such
adjustment shall be deemed to be made in the definition of "Registrable
Security" as is appropriate in order to prevent any dilution or enlargement
of the rights granted pursuant to this Agreement.
Section 2. RESTRICTIONS ON TRANSFER. The Purchaser
acknowledges and understands that in the absence of an effective Registration
Statement authorizing the resale of the Shares as provided herein, the Shares
are "restricted securities" as defined in Rule 144. The Purchaser understands
that no disposition or transfer of the Shares may be made by Purchaser in the
absence of (i) an opinion of counsel to the Purchaser, in form and substance
reasonably satisfactory to the Company, that such transfer may be made
without registration under the Securities Act or (ii) such registration.
With a view to making available to the Purchaser the
benefits of Rule 144, the Company agrees to:
(a) to comply with the provisions of paragraph (c)(1)
of Rule 144; and
(b) to file with the Commission in a timely manner
all reports and other documents required to be filed by the Company
pursuant to Section 13 or 15(d) under the Exchange Act; and, if at any
time it is not required to file such reports but in the past had been
required to or did file such reports, it will, upon the request of the
Purchaser, make available other information as required by, and so long
as necessary to permit sales of, its Registrable Securities pursuant to
Rule 144.
Section 3. REGISTRATION RIGHTS WITH RESPECT TO THE SHARES.
(a) The Company agrees that it will prepare and file
with the Securities and Exchange Commission ("Commission"), within
forty-five (45) days (plus an additional number of days equal to the
period during which Purchaser's counsel reviews the Registration
Statement pursuant to Section 3(e) herein) after the Initial Closing, a
registration statement (on Form S-1, Form S-3 and/or SB-2, or other
appropriate form of registration statement) under the Securities Act
(the "Registration Statement"), at the sole expense of the Company
(except as provided in Section 3(d) hereof), so as to permit a public
offering and resale of the Shares under the Securities Act by
Purchaser.
(b) The Company shall use commercially reasonably
efforts to cause the Registration Statement to become effective within
the earlier of (i) one hundred twenty (120) days of the date of filing
the Registration Statement, or (ii) five (5) days after receiving
written notice of SEC clearance and will within said five (5) days
request acceleration of effectiveness. The Company will notify
Purchaser of the effectiveness of the Registration Statement within one
Trading Day of such event.
(c) The Company will maintain the Registration
Statement or post-effective amendment filed under this Section 3 hereof
effective under the Securities Act from the Effective Date until no
Shares are Registrable Securities (the "Effectiveness Period").
(d) All fees, disbursements and out-of-pocket
expenses and costs incurred by the Company in connection with the
preparation and filing of the Registration Statement under subparagraph
3(a) and in complying with applicable securities and Blue Sky laws
(including, without limitation, all attorneys' fees of the Company)
shall be borne by the Company. The Purchaser shall bear the cost of
underwriting and/or brokerage discounts, fees and commissions, if any,
applicable to the Shares being registered and the fees and expenses of
its counsel.
(e) The Purchaser and its counsel shall have a
reasonable period, not to exceed five (5) Trading Days, to review the
proposed Registration Statement or any amendment thereto, prior to
filing with the Commission, and the Company shall provide the Purchaser
with copies of any comment letters received from the Commission with
respect thereto within two (2) Trading Days of receipt thereof.
(f) The Company shall make reasonably available for
inspection by Purchaser, any underwriter participating in any
disposition pursuant to the Registration
2
Statement, and any attorney, accountant or other agent retained by
the Purchaser or any such underwriter all relevant financial and
other records, pertinent corporate documents and properties of the
Company and its subsidiaries, and cause the Company's officers,
directors and employees to supply all information reasonably
requested by the Purchaser or any such underwriter, attorney,
accountant or agent in connection with the Registration Statement,
in each case, as is customary for similar due diligence
examinations; PROVIDED, HOWEVER, that all records, information and
documents that are confidential, proprietary or that contain any
material non-public information shall be kept confidential by the
Purchaser and any such underwriter, attorney, accountant or agent,
unless such disclosure is made pursuant to judicial process in a
court proceeding (after first giving the Company an opportunity
promptly to seek a protective order or otherwise limit the scope of the
information sought to be disclosed) or is required by law, or such
records, information or documents become available to the public
generally or through a third party not in violation of an accompanying
obligation of confidentiality. If the foregoing inspection and
information gathering would otherwise disrupt the Company's conduct of
its business, such inspection and information gathering shall, to the
maximum extent possible, be coordinated on behalf of the Purchaser and
the other parties entitled thereto by one firm of counsel designed by
and on behalf of the majority in interest of Purchaser and other
parties.
(g) The Company shall qualify any of the Shares for
sale in such states as the Purchaser reasonably designates and shall
furnish indemnification in the manner provided in Section 6 hereof.
However, the Company shall not be required to qualify in any state
which will require an escrow or other restriction relating to the
Company and/or the sellers, or which will require the Company to
qualify to do business in such state or require the Company to file
therein any general consent to service of process.
(h) The Company at its expense will supply the
Purchaser with copies of the Registration Statement and the final
prospectus included therein (the "Prospectus") in such quantities as
may be reasonably requested by the Purchaser.
(i) The Company shall not be required by this Section
3 to include the Purchaser's Shares in any Registration Statement which
is to be filed if, in the opinion of counsel for both the Purchaser and
the Company (or, should they not agree, in the opinion of another
counsel experienced in securities law matters acceptable to counsel for
the Purchaser and the Company) the proposed offering or other transfer
as to which such registration is requested is exempt from applicable
federal and state securities laws and would result in all purchasers or
transferees obtaining securities which are not "restricted securities",
as defined in Rule 144 under the Securities Act.
(j) If at any time or from time to time after the
effective date of the Registration Statement, the Company notifies the
Purchaser in writing of the existence of a Potential Material Event (as
defined in Section 3(k) below), the Purchaser shall not offer or sell
any Shares or engage in any other transaction involving or relating to
Shares, from the time of the giving of notice with respect to a
Potential Material Event until the Purchaser receives written notice
from the Company that such Potential Material Event
3
either has been disclosed to the public or no longer constitutes a
Potential Material Event (the "Suspension Period"). Notwithstanding
anything herein to the contrary, if a Suspension Period occurs at
any time during any period commencing on a Trading Day a Draw Down
Notice is deemed delivered and ending five (5) Trading Days
immediately following the end of the corresponding Draw Down Pricing
Period, then the Company must compensate the Purchaser for any net
decline in the market value of any Shares (i) purchased by the
Purchaser pursuant to the most recently completed Draw Down Pricing
Period (or, if applicable, during the Draw Down Pricing Period
during which the Suspension Period occurred), and (ii) sold by the
Purchaser during the five (5) Trading Days immediately following the
end of such Suspension period. Net decline shall be calculated as
the difference between the average of the Purchases Prices of the
Draw Down Shares purchased by the Purchaser pursuant to the most
recently completed Draw Down Pricing Period (or, if applicable,
during the Draw Down Pricing Period during which the Suspension
Period occurred) (the "Pre-Suspension Price") and the average price
at which the Purchaser sold the Shares in accordance with (ii)
above; PROVIDED, HOWEVER, that the Company shall only be required to
compensate the Purchaser for the net decline if the average price at
which the Purchaser sold the Shares in accordance with (ii) above is
less than 80% of the Pre-Suspension Price. If a Potential Material
Event shall occur prior to the date the Registration Statement is
filed, then the Company's obligation to file the Registration Statement
shall be delayed without penalty for not more than thirty (30) calendar
days. If lawful to do so, THE COMPANY MUST GIVE PURCHASER NOTICE IN
WRITING OF THE EXISTENCE OF A POTENTIAL MATERIAL EVENT PROMPTLY UPON
ITS DETERMINATION THAT SUCH AN EVENT EXISTS AND, WHERE POSSIBLE, AT
LEAST TWO (2) DAYS PRIOR TO THE FIRST DAY OF A SUSPENSION PERIOD.
(k) "Potential Material Event" means any of the
following: (i) the possession by the Company of material information
that is not ripe for disclosure in a registration statement or that
would be detrimental to the business and affairs of the Company if
disclosed in a Registration Statement, each as determined in good faith
by the Chief Executive Officer or the Board of Directors of the
Company; (ii) any material engagement or activity by the Company which
would, in the good faith determination of the Chief Executive Officer
or the Board of Directors of the Company, be adversely affected by
disclosure in a registration statement at such time, which
determination shall be accompanied by a good faith determination by the
Chief Executive Officer or the Board of Directors of the Company that
the Registration Statement would be materially misleading absent the
inclusion of such information, or (iii) pursuant to applicable law, a
fundamental change that requires the Company to file a post-effective
amendment to the Registration Statement, change the plan of
distribution to the Prospectus, or must update the information included
in the Prospectus pursuant to Section 10(a)(3) of the Securities Act.
Section 4. COOPERATION WITH COMPANY. The Purchaser will
cooperate with the Company in all respects in connection with this Agreement,
including timely supplying all information reasonably requested by the
Company (which shall include without limitation all information regarding the
Purchaser and proposed manner of sale of the Registrable Securities required
to be disclosed in the Registration Statement) and executing and returning
all documents
4
reasonably requested in connection with the registration and sale of the
Registrable Securities and entering into and performing its obligations under
any underwriting agreement, if the offering is an underwritten offering, in
usual and customary form, with the managing underwriter or underwriters of
such underwritten offering. The Purchaser shall consent to be named as an
underwriter in the Registration Statement. The Purchaser acknowledges that in
accordance with current Commission policy, the Purchaser will be named as the
underwriter of the Shares in the Registration Statement.
Section 5. REGISTRATION PROCEDURES. If and whenever the
Company is required by any of the provisions of this Agreement to effect the
registration of any of the Registrable Securities under the Securities Act,
the Company shall (except as otherwise provided in this Agreement), as
expeditiously as possible, subject to Sections 3(a), 3(b) and 3(e) and to the
Purchaser's assistance and cooperation as reasonably required:
(a) (i) prepare and file with the Commission such
amendments and supplements to the Registration Statement and the
Prospectus as may be necessary to keep such registration statement
effective and to comply with the provisions of the Securities Act with
respect to the sale or other disposition of all securities covered by
such registration statement whenever the Purchaser of such Registrable
Securities shall desire to sell or otherwise dispose of the same
(including prospectus supplements with respect to the sales of
securities from time to time in connection with a registration
statement pursuant to Rule 415 promulgated under the Securities Act)
and (ii) take all lawful action such that each of (A) the Registration
Statement and any amendment thereto does not, when it becomes
effective, contain an untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary to
make the statements therein not misleading and (B) the Prospectus, and
any amendment or supplement thereto, does not at any time during the
Effectiveness Period include an untrue statement of a material fact or
omit to state a material fact required to be stated therein or
necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading;
(b) (i) prior to the filing with the Commission of
any Registration Statement (including any amendments thereto) and the
distribution or delivery of the Prospectus (including any supplements
thereto), provide draft copies thereof to the Purchaser and reflect in
such documents all such comments as the Purchaser (and its counsel)
reasonably may propose and to which the Company does not reasonably
object and (ii) furnish to the Purchaser such numbers of copies of the
Prospectus including a preliminary prospectus or any amendment or
supplement to the Prospectus, as applicable, in conformity with the
requirements of the Securities Act, and such other documents, as the
Purchaser may reasonably request in order to facilitate the public sale
or other disposition of the Registrable Securities;
(c) comply with the New York blue sky laws with
respect to the Registrable Securities (subject to the limitations set
forth in Section 3(g) above), and do any and all other acts and things
which may be reasonably necessary or advisable to enable the Purchaser
to consummate the public sale or other disposition in such
5
jurisdiction of the Registrable Securities, except that the Company
shall not for any such purpose be required to qualify to do business
as a foreign corporation in any jurisdiction wherein it is not so
qualified or to file therein any general consent to service of
process;
(d) list such Registrable Securities on the Principal
Market, and any other exchange on which the Common Stock of the Company
is then listed, if the listing of such Registrable Securities is then
permitted under the rules of such exchange or the Nasdaq Stock Market;
(e) notify the Purchaser at any time when the
Prospectus is required to be delivered under the Securities Act, of the
happening of any event of which it has knowledge as a result of which
the Prospectus, as then in effect, includes an untrue statement of a
material fact or omits to state a material fact required to be stated
therein or necessary to make the statements therein not misleading in
the light of the circumstances then existing, and the Company shall
promptly prepare and file a curative amendment or curative supplement
under Section 5(a) as quickly as commercially possible and the period
beginning on the date of notice until the curative amendment is
effective or curative supplement is provided to the Purchaser shall be
deemed a Suspension Period and the Company shall compensate the
Purchaser as set forth in Section 3(j) herein;
(f) as promptly as practicable after becoming aware
of such event, notify the Purchaser (or, in the event of an
underwritten offering, the managing underwriters) of the issuance by
the Commission or any state authority of any stop order or other
suspension of the effectiveness of the Registration Statement at the
earliest possible time and take all lawful action to effect the
withdrawal, rescission or removal of such stop order or other
suspension;
(g) take all such other lawful actions reasonably
necessary to facilitate the disposition by the Purchaser of its
Registrable Securities in accordance with the methods therefor provided
in the Prospectus which are customary for issuers to perform under the
circumstances;
(h) in the event of an underwritten offering,
promptly include or incorporate in a prospectus supplement or
post-effective amendment to the Registration Statement such information
as the managing underwriters reasonably agree should be included
therein and to which the Company does not reasonably object and make
all required filings of such prospectus supplement or post-effective
amendment as soon as practicable after it is notified of the matters to
be included or incorporated in such prospectus supplement or
post-effective amendment; and
(i) maintain a transfer agent for its Common Stock.
Section 6. INDEMNIFICATION.
(a) The Company agrees to indemnify and hold harmless
the Purchaser and each person, if any, who controls the Purchaser
within the meaning of the Securities
6
Act ("Distributing Purchaser") against any losses, claims,
damages or liabilities, joint or several (which shall, for all
purposes of this Agreement, include, but not be limited to, all
reasonable costs of defense and investigation and all reasonable
attorneys' fees), to which the Distributing Purchaser may become
subject, under the Securities Act or otherwise, insofar as such
losses, claims, damages or liabilities (or actions in respect
thereof) arise out of or are based upon any untrue statement or
alleged untrue statement of any material fact contained in the
Registration Statement, or any related preliminary prospectus, the
Prospectus or amendment or supplement thereto, or arise out of or
are based upon the omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the
statements therein in light of the circumstances when made not
misleading; provided, however, that the Company will not be liable
in any such case to the extent that any such loss, claim, damage or
liability arises out of or is based upon an untrue statement or
alleged untrue statement or omission or alleged omission made in the
Registration Statement, preliminary prospectus, the Prospectus or
amendment or supplement thereto in reliance upon, and in conformity
with, written information furnished to the Company by the
Distributing Purchaser specifically for use in the preparation
thereof. This Section 6(a) shall not inure to the benefit of any
Distributing Purchaser with respect to any person asserting such
loss, claim, damage or liability who purchased the Registrable
Securities which are the subject thereof if the Distributing
Purchaser failed to send or give a copy of the Prospectus to such
person at or prior to the written confirmation to such person of the
sale of such Registrable Securities, where the Distributing
Purchaser was obligated to do so under the Securities Act or the
rules and regulations promulgated thereunder. This indemnity
agreement will be in addition to any liability which the Company may
otherwise have.
(b) Each Distributing Purchaser agrees that it will
indemnify and hold harmless the Company, and each officer, director of
the Company or person, if any, who controls the Company within the
meaning of the Securities Act, against any losses, claims, damages or
liabilities (which shall, for all purposes of this Agreement, include,
but not be limited to, all reasonable costs of defense and
investigation and all reasonable attorneys' fees) to which the Company
or any such officer, director or controlling person may become subject
under the Securities Act or otherwise, insofar as such losses, claims,
damages or liabilities (or actions in respect thereof) arise out of or
are based upon any untrue statement or alleged untrue statement of any
material fact contained in the Registration Statement, or any related
preliminary prospectus, the Prospectus or amendment or supplement
thereto, or arise out of or are based upon the omission or the alleged
omission to state therein a material fact required to be stated therein
or necessary to make the statements therein not misleading, but in each
case only to the extent that such untrue statement or alleged untrue
statement or omission or alleged omission was made in the Registration
Statement, preliminary prospectus, the Prospectus or amendment or
supplement thereto in reliance upon, and in conformity with, written
information furnished to the Company by such Distributing Purchaser
specifically for use in the preparation thereof. This indemnity
agreement will be in addition to any liability which the Distributing
Purchaser may otherwise have. Notwithstanding anything to the contrary
herein, the Distributing Purchaser shall not be liable under this
Section 6(b) for any
7
amount in excess of the net proceeds to such Distributing
Purchaser as a result of the sale of Registrable Securities
pursuant to the Registration Statement.
(c) Promptly after receipt by an indemnified party
under this Section 6 of notice of the commencement of any action, such
indemnified party will, if a claim in respect thereof is to be made
against the indemnifying party under this Section 6, notify the
indemnifying party of the commencement thereof; but the omission so to
notify the indemnifying party will not relieve the indemnifying party
from any liability which it may have to any indemnified party except to
the extent of actual prejudice demonstrated by the indemnifying party.
In case any such action is brought against any indemnified party, and
it notifies the indemnifying party of the commencement thereof, the
indemnifying party will be entitled to participate in, and, to the
extent that it may wish, jointly with any other indemnifying party
similarly notified, assume the defense thereof, subject to the
provisions herein stated and after notice from the indemnifying party
to such indemnified party of its election so to assume the defense
thereof, the indemnifying party will not be liable to such indemnified
party under this Section 6 for any legal or other expenses subsequently
incurred by such indemnified party in connection with the defense
thereof other than reasonable costs of investigation, unless the
indemnifying party shall not pursue the action to its final conclusion.
The indemnified party shall have the right to employ separate counsel
in any such action and to participate in the defense thereof, but the
fees and expenses of such counsel shall not be at the expense of the
indemnifying party if the indemnifying party has assumed the defense of
the action with counsel reasonably satisfactory to the indemnified
party; provided that if the indemnified party is the Distributing
Purchaser, the fees and expenses of such counsel shall be at the
expense of the indemnifying party if (i) the employment of such counsel
has been specifically authorized in writing by the indemnifying party,
or (ii) the named parties to any such action (including any impleaded
parties) include both the Distributing Purchaser and the indemnifying
party and the Distributing Purchaser shall have been advised by such
counsel in writing that there may be one or more legal defenses
available to the indemnifying party different from or in conflict with
any legal defenses which may be available to the Distributing Purchaser
(in which case the indemnifying party shall not have the right to
assume the defense of such action on behalf of the Distributing
Purchaser, it being understood, however, that the indemnifying party
shall, in connection with any one such action or separate but
substantially similar or related actions in the same jurisdiction
arising out of the same general allegations or circumstances, be liable
only for the reasonable fees and expenses of one separate firm of
attorneys for the Distributing Purchaser, which firm shall be
designated in writing by the Distributing Purchaser and be approved by
the indemnifying party). No settlement of any action against an
indemnified party shall be made without the prior written consent of
the indemnified party, which consent shall not be unreasonably
withheld.
All fees and expenses of the indemnified party
(including reasonable costs of defense and investigation in a manner
not inconsistent with this Section and all reasonable attorneys' fees
and expenses) shall be promptly paid to the indemnified party, as
incurred; within 10 Trading Days of written notice thereof to the
indemnified party; provided, that the indemnifying party may require
such indemnified party to undertake to
8
reimburse all such fees and expenses to the extent it is
finally judicially determined that such indemnified party
is not entitled to indemnification hereunder.
Section 7. CONTRIBUTION. In order to provide for
just and equitable contribution under the Securities Act in any case
in which (i) the indemnified party makes a claim for indemnification
pursuant to Section 6 hereof but it is judicially determined (by the
entry of a final judgment or decree by a court of competent
jurisdiction and the expiration of time to appeal or the denial of
the last right of appeal) that such indemnification may not be
enforced in such case notwithstanding the fact that the express
provisions of Section 6 hereof provide for indemnification in such
case, or (ii) contribution under the Securities Act may be required
on the part of any indemnified party, then the Company and the
applicable Distributing Purchaser shall contribute to the aggregate
losses, claims, damages or liabilities to which they may be subject
(which shall, for all purposes of this Agreement, include, but not
be limited to, all reasonable costs of defense and investigation and
all reasonable attorneys' fees), in either such case (after
contribution from others) on the basis of relative fault as well as
any other relevant equitable considerations. The relative fault
shall be determined by reference to, among other things, whether the
untrue or alleged untrue statement of a material fact or the
omission or alleged omission to state a material fact relates to
information supplied by the Company on the one hand or the
applicable Distributing Purchaser on the other hand, and the
parties' relative intent, knowledge, access to information and
opportunity to correct or prevent such statement or omission. The
Company and the Distributing Purchaser agree that it would not be
just and equitable if contribution pursuant to this Section 7 were
determined by pro rata allocation or by any other method of
allocation which does not take account of the equitable
considerations referred to in this Section 7. The amount paid or
payable by an indemnified party as a result of the losses, claims,
damages or liabilities (or actions in respect thereof) referred to
above in this Section 7 shall be deemed to include any legal or
other expenses reasonably incurred by such indemnified party in
connection with investigating or defending any such action or claim.
No person guilty of fraudulent misrepresentation (within the meaning
of Section 11(f) of the Securities Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent
misrepresentation.
Notwithstanding any other provision of this
Section 7, in no event shall any (i) Purchaser be required to
undertake liability to any person under this Section 7 for any
amounts in excess of the dollar amount of the net proceeds to be
received by the Purchaser from the sale of the Purchaser's
Registrable Securities (after deducting any fees, discounts and
commissions applicable thereto) pursuant to any Registration
Statement under which such Registrable Securities are or were to be
registered under the Securities Act and (ii) underwriter be required
to undertake liability to any person hereunder for any amounts in
excess of the aggregate discount, commission or other compensation
payable to such underwriter with respect to the Registrable
Securities underwritten by it and distributed pursuant to the
Registration Statement.
Section 8. NOTICES. All notices, demands,
requests, consents, approvals, and other communications required or
permitted hereunder shall be in writing and, unless otherwise
specified herein, shall be delivered as set forth in the Purchase
Agreement.
9
Section 9. ASSIGNMENT. Neither this Agreement nor
any rights of the Purchaser or the Company hereunder may be assigned
by either party to any other person. Notwithstanding the foregoing,
upon the prior written consent of the Company, which consent shall
not be unreasonably withheld or delayed in the case of an assignment
to an affiliate of the Purchaser, the Purchaser's interest in this
Agreement may be assigned at any time, in whole or in part, to any
affiliate of the Purchaser, who agrees to be bound hereby.
Section 10. COUNTERPARTS/FACSIMILE. This Agreement
may be executed in two or more counterparts, each of which shall
constitute an original, but all of which, when together shall
constitute but one and the same instrument, and shall become
effective when one or more counterparts have been signed by each
party hereto and delivered to the other party. In lieu of the
original, a facsimile transmission or copy of the original shall be
as effective and enforceable as the original.
Section 11. REMEDIES AND SEVERABILITY. The
remedies provided in this Agreement are cumulative and not exclusive
of any remedies provided by law. If any term, provision, covenant or
restriction of this Agreement is held by a board of arbitration or a
court of competent jurisdiction to be invalid, illegal, void or
unenforceable, the remainder of the terms, provisions, covenants and
restrictions set forth herein shall remain in full force and effect
and shall in no way be affected, impaired or invalidated, and the
parties hereto shall use their best efforts to find and employ an
alternative means to achieve the same or substantially the same
result as that contemplated by such term, provision, covenant or
restriction. It is hereby stipulated and declared to be the
intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any
of those that may be hereafter declared invalid, illegal, void or
unenforceable.
Section 12. ENTIRE AGREEMENT; AMENDMENT AND
WAIVER. This Agreement and the other Transaction Documents (as
defined in the Purchase Agreement) constitute the entire
understanding of the parties with respect to the subject matter
hereof and thereof and supersede any and all prior understandings
and agreements, whether written or oral, with respect to such
subject matter. Neither this Agreement nor any term may be amended,
waived, discharged or terminated, except by written instrument
signed by the Company and the holders of Registrable Securities.
Section 13. CONFLICTING AGREEMENTS. The Company
shall not enter into any agreement with respect to its securities
that is inconsistent with the rights granted to the Purchasers in
this Agreement or otherwise prevents the Company from complying with
all of its obligations hereunder.
Section 14. HEADINGS. The headings in this
Agreement are for reference purposes only and shall not affect in
any way the meaning or interpretation of this Agreement.
Section 15. GOVERNING LAW. This Agreement shall be
governed by and construed in accordance with the laws of the State
of New York applicable to contracts made in New York by persons
domiciled in New York City and without regard to its principles of
conflicts of laws. The Company and the Purchaser agree to submit
themselves to the IN PERSONAM jurisdiction of
10
the state and federal courts situated within the Southern District
of the State of New York with regard to any controversy arising out
of or relating to this Agreement. Any party shall have the right to
seek injunctive relief from any court of competent jurisdiction in
any case where such relief is available. Any dispute under this
Agreement shall be submitted to arbitration under the American
Arbitration Association (the "AAA") in New York City, New York, and
shall be finally and conclusively determined by the decision of a
board of arbitration consisting of three (3) members (hereinafter
referred to as the "Board of Arbitration") selected as according to
the rules governing the AAA. The Board of Arbitration shall meet on
consecutive business days in New York City, New York, and shall
reach and render a decision in writing (concurred in by a majority
of the members of the Board of Arbitration) with respect to the
amount, if any, which the losing party is required to pay to the
other party in respect of a claim filed. In connection with
rendering its decisions, the Board of Arbitration shall adopt and
follow the laws of the State of New York. To the extent practical,
decisions of the Board of Arbitration shall be rendered no more than
thirty (30) calendar days following commencement of proceedings with
respect thereto. The Board of Arbitration shall cause its written
decision to be delivered to all parties involved in the dispute. The
Board of Arbitration shall be authorized and is directed to enter a
default judgment against any party refusing to participate in the
arbitration proceeding within thirty days of any deadline for such
participation. Any decision made by the Board of Arbitration (either
prior to or after the expiration of such thirty (30) calendar day
period) shall be final, binding and conclusive on the parties to the
dispute, and entitled to be enforced to the fullest extent permitted
by law and entered in any court of competent jurisdiction. The
prevailing party shall be awarded its costs, including reasonable
attorneys' fees, from the non-prevailing party as part of the
arbitration award. Any party shall have the right to seek injunctive
relief from any court of competent jurisdiction in any case where
such relief is available. The prevailing party in such injunctive
action shall be awarded its costs, including reasonable attorney's
fees, from the non-prevailing party.
[SIGNATURE PAGE FOLLOWS]
11
[SIGNATURE PAGE TO REGISTRATION RIGHTS REGISTRATION RIGHTS AGREEMENT]
IN WITNESS WHEREOF, the parties hereto have caused
this Registration Rights Agreement to be duly executed, on this 10th
day of May, 2001
STEMCELLS, INC.
By: /s/ Martin McGlynn
--------------------------------------
Martin McGlynn, President & CEO
SATIVUM INVESTMENTS LIMITED
By: /s/ David Sims
--------------------------------------
David Sims, Director
12